180 related articles for article (PubMed ID: 34100959)
1. Spinal fluid IgG antibodies from patients with demyelinating diseases bind multiple sclerosis-associated bacteria.
Eckman E; Laman JD; Fischer KF; Lopansri B; Martins TB; Hill HR; Kriesel JD
J Mol Med (Berl); 2021 Oct; 99(10):1399-1411. PubMed ID: 34100959
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal synthesis of antibodies to staphylococcal antigens in multiple sclerosis patients.
Aasjord P; Nyland H; Haaheim LR
Acta Pathol Microbiol Immunol Scand C; 1986 Jun; 94(3):97-103. PubMed ID: 3751587
[TBL] [Abstract][Full Text] [Related]
3. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
4. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
Blauth K; Soltys J; Matschulat A; Reiter CR; Ritchie A; Baird NL; Bennett JL; Owens GP
Acta Neuropathol; 2015 Dec; 130(6):765-81. PubMed ID: 26511623
[TBL] [Abstract][Full Text] [Related]
5. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
Persson L; Longhi S; Enarsson J; Andersen O; Haghigi S; Nilsson S; Lagging M; Johansson M; Bergström T
J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
[TBL] [Abstract][Full Text] [Related]
6. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
Warren KG; Catz I
Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
[TBL] [Abstract][Full Text] [Related]
8. Anti-myelin antibodies in cerebrospinal fluid and serum of patients with meningopolyneuritis Garin-Bujadoux-Bannwarth and other neurological diseases.
Suchanek G; Kristoferitsch W; Stanek G; Bernheimer H
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Dec; 263(1-2):160-8. PubMed ID: 3577478
[TBL] [Abstract][Full Text] [Related]
9. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker.
Krametter D; Niederwieser G; Berghold A; Birnbaum G; Strasser-Fuchs S; Hartung HP; Archelos JJ
Mult Scler; 2001 Feb; 7(1):13-8. PubMed ID: 11321187
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
Rawes JA; Calabrese VP; Khan OA; DeVries GH
Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635
[TBL] [Abstract][Full Text] [Related]
11. Increased reactivity to HTLV-I in inflammatory nervous system diseases.
Lolli F; Fredrikson S; Kam-Hansen S; Link H
Ann Neurol; 1987 Jul; 22(1):67-71. PubMed ID: 2888429
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls.
Xiao BG; Linington C; Link H
J Neuroimmunol; 1991 Feb; 31(2):91-6. PubMed ID: 1991822
[TBL] [Abstract][Full Text] [Related]
13. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
[TBL] [Abstract][Full Text] [Related]
14. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
[TBL] [Abstract][Full Text] [Related]
15. Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis.
Sellebjerg F; Jensen J; Ryder LP
J Neuroimmunol; 1998 Apr; 84(2):179-87. PubMed ID: 9628461
[TBL] [Abstract][Full Text] [Related]
16. Identification of the major HHV-6 antigen recognized by cerebrospinal fluid IgG in multiple sclerosis.
Alenda R; Álvarez-Lafuente R; Costa-Frossard L; Arroyo R; Mirete S; Álvarez-Cermeño JC; Villar LM
Eur J Neurol; 2014 Aug; 21(8):1096-1101. PubMed ID: 24724742
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid anti-cardiolipin antibodies in neurological diseases.
Lolli F; Matá S; Baruffi MC; Amaducci L
Clin Immunol Immunopathol; 1991 May; 59(2):314-21. PubMed ID: 2009647
[TBL] [Abstract][Full Text] [Related]
18. Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: discrimination between microorganism-driven and polyspecific immune response.
Jacobi C; Lange P; Reiber H
J Neuroimmunol; 2007 Jul; 187(1-2):139-46. PubMed ID: 17512988
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid antibodies to tubulin are elevated in the patients with multiple sclerosis.
Svarcová J; Fialová L; Bartos A; Steinbachová M; Malbohan I
Eur J Neurol; 2008 Nov; 15(11):1173-9. PubMed ID: 18973612
[TBL] [Abstract][Full Text] [Related]
20. Cells producing antibodies specific for myelin basic protein region 70-89 are predominant in cerebrospinal fluid from patients with multiple sclerosis.
Martino G; Olsson T; Fredrikson S; Hojeberg B; Kostulas V; Grimaldi LM; Link H
Eur J Immunol; 1991 Dec; 21(12):2971-6. PubMed ID: 1721023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
